Your browser doesn't support javascript.
loading
Amino acids to prevent cardiac surgery-associated acute kidney injury: a randomized controlled trial.
Kazawa, Masahiro; Kabata, Daijiro; Yoshida, Hisako; Minami, Kimito; Maeda, Takuma; Yoshitani, Kenji; Matsuda, Hitoshi; Shintani, Ayumi.
Affiliation
  • Kazawa M; Department of Critical Care Medicine, National Cerebral and Cardiovascular Center, 6-1, Kishibe-Shinmachi, Suita, Osaka, Japan. mas.kazawa@gmail.com.
  • Kabata D; Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. mas.kazawa@gmail.com.
  • Yoshida H; Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Minami K; Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Maeda T; Department of Critical Care Medicine, National Cerebral and Cardiovascular Center, 6-1, Kishibe-Shinmachi, Suita, Osaka, Japan.
  • Yoshitani K; Department of Anesthesiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
  • Matsuda H; Department of Anesthesiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
  • Shintani A; Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.
JA Clin Rep ; 10(1): 19, 2024 Mar 26.
Article in En | MEDLINE | ID: mdl-38528235
ABSTRACT

BACKGROUND:

This study aimed to examine the preventive effect of amino acids on postoperative acute kidney injury (AKI).

METHODS:

This was single-center, patient- and assessor-blinded, randomized controlled trial. Patients who underwent aortic surgery with cardiopulmonary bypass were included. The intervention group received 60 g/day of amino acids for up to 3 days. The control group received standard care. The primary outcome was the incidence of AKI. We assessed the effect of amino acids on AKI using a Cox proportional hazards regression model.

RESULTS:

Sixty-six patients were randomly assigned to the control or intervention group. One patient in the control group withdrew consent after randomization. The incidence of AKI was 10 patients (30.3%) in the intervention group versus 18 patients (56.2%) in the control group (adjusted hazard ratio, 0.44; 95% confidence interval, 0.20-0.95; P = 0.04).

CONCLUSIONS:

This trial demonstrated a significant reduction in AKI incidence with amino acid supplementation. TRIAL REGISTRATION jRCT, jRCTs051210154. Registered 31 December 2021, https//jrct.niph.go.jp/re/reports/detail/69916.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JA Clin Rep Year: 2024 Document type: Article Affiliation country: Japan Publication country: ALEMANHA / ALEMANIA / DE / DEUSTCHLAND / GERMANY

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JA Clin Rep Year: 2024 Document type: Article Affiliation country: Japan Publication country: ALEMANHA / ALEMANIA / DE / DEUSTCHLAND / GERMANY